Dr. Fatima Al Mansoori

Dr. Fatima Al Mansoori is a leading female medical oncologist at American Hospital Dubai, one of the UAE's premier JCI-accredited hospitals offering American-standard oncology care. As one of the relatively few Emirati women to reach the highest echelons of cancer medicine, Dr. Al Mansoori is a role model within the UAE's healthcare transformation agenda and a respected voice in women's cancer advocacy across the Gulf region.

With 18 years of oncology practice, Dr. Al Mansoori focuses primarily on breast and gynecologic cancers, bringing a precision medicine approach to every patient encounter. She integrates molecular pathology, next-generation sequencing results, and clinical trial eligibility into her treatment planning, ensuring that patients receive the most current evidence-based therapy available.

Dr. Al Mansoori leads a multidisciplinary tumor board at American Hospital Dubai that convenes weekly to review complex cases in breast and gynecologic oncology. The board includes surgical oncologists, radiation oncologists, radiologists, and pathologists, ensuring that each patient's plan reflects the full spectrum of specialist input. She is particularly experienced in managing patients with BRCA1 and BRCA2 mutations, coordinating risk-reducing strategies alongside active cancer treatment.

Her cultural sensitivity and fluency in both Arabic and English make her exceptionally effective in communicating with UAE national patients and their families, particularly in the emotionally complex context of cancer diagnosis and treatment decisions.

Dr. Al Mansoori completed her MBBS at UAE University and went on to earn her MRCP (Member of the Royal College of Physicians) in the United Kingdom following residency training in London. She completed a Medical Oncology fellowship at The Royal Marsden Hospital in Surrey, UK — one of the world's leading cancer centers — where she received specialist training in breast and gynecologic malignancies. She subsequently completed a focused breast oncology fellowship at MD Anderson Cancer Center, Houston, USA. She holds the FRCR designation and maintains ongoing oncology board certification. She has participated in clinical trials training programs through ASCO's educational initiative.

Dr. Al Mansoori's clinical practice centers on breast cancer at all stages, from early-stage hormone receptor-positive disease through metastatic HER2-positive and triple-negative breast cancer. She prescribes and manages cytotoxic chemotherapy regimens, targeted agents (trastuzumab, pertuzumab, CDK4/6 inhibitors, PARP inhibitors), and immunotherapy (checkpoint inhibitors for eligible patients). In gynecologic oncology, she manages ovarian, endometrial, cervical, and vulvar cancers, with expertise in PARP inhibitor maintenance therapy for platinum-sensitive recurrent ovarian cancer. She conducts bone marrow aspirations and biopsies for staging, and coordinates closely with the interventional radiology team for image-guided biopsies and port placement.

Dr. Al Mansoori participates in international clinical trials conducted through American Hospital Dubai's oncology research program. She has contributed to regional epidemiological studies examining breast cancer incidence and stage at presentation among Gulf Arab women — a population with younger average age at diagnosis compared to Western counterparts. She has presented at the Emirates Oncology Society annual conference and co-authored papers in peer-reviewed oncology journals. She collaborates with the Gulf Cancer Society on awareness campaigns targeting early breast cancer detection.

American Hospital Dubai's oncology department is experienced in managing international patients seeking second opinions or continuing cancer treatment while residing in or traveling through the UAE. Dr. Al Mansoori consults in Arabic and English and is accustomed to coordinating care with oncologists in other countries, reviewing overseas pathology and imaging, and providing written second-opinion reports. Video consultations enable patients from across the Arab world, South Asia, and East Africa to obtain specialist input without travel. American Hospital Dubai's patient relations team provides visa assistance, accommodation liaison, and insurance pre-authorization support for international oncology patients.

Dr. Al Mansoori has received recognition from the Emirates Oncology Society for her contributions to women's cancer care in the UAE. She has been featured in Gulf Health media as a leading voice in breast cancer awareness and early detection among Arab women. She is a recipient of the American Hospital Dubai's Clinical Excellence Award and serves on the hospital's Ethics Committee.